MAPK3 and lymphoma: In our hands, 2-AG did not induce activation of ERK1/2 pathway in lymphoma cells, in contrast to reports on other cell types such as CB2-transfected CHO cells and CB1 and CB2 expressing microglial cells [47,56,57].